ϩ -based intracellular solutions showed enhanced amplitude with multiphasic decay and diastolic depolarization-induced facilitation. The characteristics of I CaL in this population of cells were not due to contamination by other currents or an artifact. These phenomena were reduced by ryanodine, caffeine, cyclopiazonic acid, the protein kinase A inhibitor H-89, and the cAMP-dependent protein kinase inhibitor. Forskolin and isoproterenol increased I CaL by only ϳ60% in these cells.
SINCE INTRACELLULAR CALCIUM IONS were first shown to participate in the inactivation of the L-type Ca 2ϩ current (I CaL ) in cardiac muscle cells (24) , Ca 2ϩ -dependent inactivation of I CaL has been extensively studied (1, 10, 13, 16, 30, 34) . It is now considered that calcium ions exert their effect via calmodulin linked to an IQ motif of the ␣ 1c -subunit (28) . In cardiac muscle the Ca 2ϩ responsible for inactivation may enter the cell via sarcolemmal Ca 2ϩ channels (13) and/or be released from the sarcoplasmic reticulum (SR) (34) . There is close cross talk between I CaL (the dihydropyridine receptor, DHPr) and the SR Ca 2ϩ release channel sensitive to Ca 2ϩ (the ryanodine receptor, RyR) (7) . This association has been directly observed in rabbit ventricular myocytes with the use of double-labeled immunofluorescence and confocal microscopy (8) , and functional coupling between DHPr and RyR has been described in rat ventricular myocytes (32, 33) . Thus the DHPr, by their close association with RyR in microdomains, regulate the release of Ca 2ϩ into the cytosol, which in turn regulates I CaL through Ca 2ϩ -dependent inactivation. Ca 2ϩ current can be upregulated through different mechanisms. The best known of these is phosphorylation of the channel by a cAMP-dependent protein kinase (PKA) following stimulation of ␤-adrenergic receptors (9) . During an action potential, increased entry of Ca 2ϩ following the phosphorylation of DHPrs has to be regulated to avoid Ca 2ϩ overload. This is done through different mechanisms such as increased K ϩ current and Ca 2ϩ -dependent inactivation of the DHPr (5). Another mechanism that leads to Ca 2ϩ current upregulation is facilitation. In cardiac cells an increase in the frequency of activation of Ca 2ϩ channels over a physiological range (0.5-5 Hz) induces an increase of the Ca 2ϩ current (11, 21, 29) . Recently it was also shown (3) that moderate depolarization of the diastolic membrane potential also promotes facilitation of I CaL , which is enhanced by intracellular cAMP.
The aim of the present study was to investigate the mechanism that underlies multiphasic inactivation of I CaL that was recorded in our experiments. In vitro patch-clamp studies of calcium current usually seek to avoid contamination by other currents by substituting physiological Na ϩ and K ϩ by impermeant ions like Cs ϩ . We show that intracellular Cs ϩ activates the PKA-dependent pathway leading to the phosphorylation of the DHPr and/or the RyR and/or the regulatory protein of the SR Ca 2ϩ -ATPase (SERCA), phospholamban (PLB). Such phosphorylation underlies very fast and reversible Ca 2ϩ -dependent inactivation of I CaL .
MATERIALS AND METHODS
Cell isolation. All studies complied with the French Home Office Regulations Governing the Care and Use of Laboratory Animals. Ventricular myocytes were enzymatically dissociated from adult guinea pig hearts as described previously (20) . Isolated cells were placed in a 1.5-ml Perspex chamber on the stage of an inverted microscope (Nikon Diaphot) and used between 2 and 8 h after cell isolation. The chamber was continuously perfused at a rate of 1-2 ml/min with a Tyrode solution (see Table 1 ). All experiments were performed at room temperature (ϳ23°C) Solutions. Experimental solutions are shown in Table 1 . Extracellular test solutions were applied by using a multiple microcapillary perfusion system (19) placed in close proximity to the cell (0.5 mm). All salts and drugs were purchased from Sigma Chemicals, except H-89, which was obtained from Calbiochem. CdCl 2, 4-aminopyridine (4-AP), and caffeine were added to the external solutions at the concentrations given. Stock solutions of tetrodotoxin (TTX; 1 mmol/l), cyclopiazonic acid (CPA; 10 mmol/l), ryanodine (10 mmol/l), H-89 (1 mmol/l), forskolin (1 mmol/l), and isoproterenol (1 mmol/l) were prepared in distilled water and added to the external solutions to provide the concentrations indicated. Experiments involving the use of nifedipine (100 mol/l, stock solution 10 mmol/l in ethanol) were performed in the dark. Protein kinase inhibitor (PKI; 200 nmol/l, stock solution 1 mmol/l in distilled water) was included in the internal solution of one set of experiments (see Fig. 5 ).
Cell current measurements. Ca 2ϩ currents were recorded using the whole cell configuration of the patch-clamp technique. In most of the experiments, conditions were optimized to eliminate currents other than I CaL by using Na ϩ -K ϩ -free solutions (see Table 1 , Na ϩ -K ϩ -free extracellular and Cs ϩ intracellular solutions). In some experiments (e.g., see Figs. 6 and 7), different solutions were used to record I CaL (Table 1) . Junction potentials between the intrapipette solution and the reference electrode were canceled before tight seals were obtained. The pipettes were obtained from borosilicate glass tubes (GC150F-15; Clark Electromedical Instrument) with a puller (PC103; Narashige, Tokyo, Japan) and slightly firepolished (MF-9; Narashige). When filled with the pipette solution, pipette resistance was 1.5-3 M⍀. In some experiments, pipettes were coated with dental wax and pipette and cell capacitance were compensated. The series resistance was compensated by 50-70%. In other experiments, voltage errors resulting from uncompensated series resistance were Ͻ5 mV and were not corrected. Cell membrane capacitance was measured by integrating the capacitance current recorded during a 10-mV hyperpolarizing pulse from a holding potential of Ϫ80 mV. The voltage clamp circuit was provided by an RK 400 patch-clamp amplifier (Biologic, Grenoble, France). Voltage parameters were controlled by a Pentium PC connected through a DIGIDATA 1200 analog interface (Axon Instruments, Burlingame, CA). Data acquisition and analysis were accomplished using pCLAMP software (Axon Instruments). Sampling frequency was 10 kHz, and signals were filtered at 3 kHz with the use of an 8-pole Butterworth filter before acquisition.
I CaL was elicited with 300-or 500-ms voltage steps to 0 mV from a holding potential of Ϫ80 mV at a frequency of 0.125 Hz. I CaL was measured as the difference between the peak inward current and the current at the end of the depolarizing pulse. Currents are expressed in current density (pA/pF). Current-voltage (I-V) relationships and availability (steadystate inactivation) curves were obtained with a double pulse protocol that consisted of 500-ms-duration prepulses from Ϫ80 to ϩ60 mV in 10-mV steps, a 5-ms interpulse interval at Ϫ80 mV, and a test pulse to 0 mV for 500 ms. The stimulus frequency was 0.125 Hz. Availability curves were obtained by normalization of the amplitude of the test pulse current to its amplitude recorded in the absence of a prepulse.
Results are expressed as means Ϯ SE (n ϭ no. of cells). Statistical differences were assayed by using one-or two-way ANOVA as appropriate, followed by the post hoc Dunnett's test. Statistics were performed by using SigmaStat version 1.0 software. Figure 1 , A and B, shows records of Ca 2ϩ currents evoked at three voltages (Ϫ20, Ϫ10, and 0 mV) in two different myocytes that exhibit totally different kinetic patterns of inactivation. The records shown in Fig. 1A are typical of 18% of the cells (n ϭ 90), where the currents showed classic exponential decay of I CaL . The records shown in Fig. 1B are typical of 82% of the cells, which had more complex current inactivation, with a presence of a notch indicating the separation of two distinct phases of decay. All of these experiments were conducted with the Na ϩ -K ϩ -free extracellular solution and the Cs ϩ -based intracellular solution described in Table 1 . Figure 1C shows the I-V curves obtained from these two types of cells. Cells that showed simple decay of I CaL had smaller currents than cells with complex inactivation of I CaL (P Ͻ 0.05, all voltages). The availability curves recorded in these cells were also quite different (Fig. 1D ). In cells with complex inactivation of I CaL , diastolic depolarization of prepulses between Ϫ80 and Ϫ40 mV induced facilitation of the current (3). Such facilitation did not occur in availability curves from cells with simple decay of I CaL (Fig. 1D) .
RESULTS

Different behavior in the time course of decay of I CaL .
We examined various alternative explanations for this variability of the kinetics of I CaL from different myocytes. This variability was observed in different cells obtained from the same batches of cell isolations, so it was not a consequence of the quality of the cell isolation procedure. Interestingly, complex inactivation of I CaL was always prominent at negative voltages (Ϫ20 mV in Fig. 1B ), whereas it appeared as a break point or notch between two distinct phases of decay of I CaL between Ϫ10 and 10 mV. We rejected any methodological problems such as voltage clamp control or lack of clamp uniformity provoking this irregularity because, first, the I-V curves had the same shape whether decay was simple or complex ( Fig. 1C) , and second, if there was loss of voltage control, the irregu- larity would be more prominent at positive voltages where the current was larger. It was verified that series resistance and cell capacitance compensation up to 70% did not affect the shape of the current (n ϭ 10).
Despite the lack of a shoulder in the I-V relationships at negative potentials, we looked for possible contamination of I CaL by the fast Na ϩ current (I Na ; notwithstanding that the external solution was Na ϩ free), the TTX-sensitive Ca 2ϩ current (14) , and the T-type Ca 2ϩ current (I CaT ). The addition of 30 M TTX to the external solution had no effect on the shape of recorded I CaL (n ϭ 6). The addition of 40 M Ni 2ϩ , a concentration known to block I CaT without affecting I CaL (26) , had no effect (n ϭ 6; Fig. 2A ). Transient outward K ϩ currents (I TO ), which are present in cardiac cells from other species, are sensitive to 4-AP and/or to intracellular Ca 2ϩ . Although our experiments were conducted with a Cs ϩ -rich intracellular solution that did not contain K ϩ , we tested the effect of the addition of 2 mM 4-AP, which blocks Ca 2ϩ -insensitive transient outward currents. This had no effect (n ϭ 9; Fig. 2B ). Also a transient outward current was not revealed when either external Ca 2ϩ was removed from the medium (n ϭ 2) or when I CaL was blocked by an inorganic blocker (200 M Cd 2ϩ , n ϭ 5; data not shown) or by an organic blocker (100 M nifedipine, n ϭ 8; Fig. 2C ). We next examined whether calcium ions had to flow through the Ca 2ϩ channels to induce multiphasic inactivation. Figure 2D shows that, after substitution of Ca 2ϩ by Ba 2ϩ , notched decay of the current was no longer visible (n ϭ 6). Also, complex inactivation of I CaL was not observed in experiments where BAPTA replaced EGTA in the pipette solution (n ϭ 10; Fig. 2E ).
These last results suggest that multiphasic decay of the current resulted from Ca 2ϩ influx and accumulation beneath the membrane.
Origin of the Ca 2ϩ dependence of complex decay of I CaL . In the following experiments, the involvement of the SR in multiphasic inactivation of the L-type Ca 2ϩ current in Cs ϩ -loaded myocytes due to Ca 2ϩ -induced Ca 2ϩ release (CICR) was tested. In the presence of 100 M ryanodine, the Ca 2ϩ release channel (RyR) of the SR is unable to release Ca 2ϩ stored in the SR, whereas sarcolemmal L-type Ca 2ϩ channels are unaffected (18, 23) . Figure 3A shows that the application of 100 M of ryanodine induced the disappearance of notched decay, a slowing down of the inactivation phase of the current, and an increase of the current amplitude. In addition, prepulse voltage facilitation disappeared with ryanodine (Fig. 3B) . Similar results were obtained after the application of either 100 M CPA (n ϭ 3), which prevents Ca 2ϩ loading of the SR (37), or 10 mM caffeine (n ϭ 5), which causes emptying of the SR. The notched decay of I CaL was therefore a direct consequence of Ca 2ϩ released from the SR. The notched and multiphasic decay of I CaL were more prominent at negative voltages (Fig. 1A) . To further characterize this relationship, we evaluated the CICR-sensitive part of the current by subtracting control currents from those recorded after the application of 100 M ryanodine (Fig. 4A) . Interestingly, the form of these difference currents exhibited kinetics similar to estimated SR Ca 2ϩ release fluxes from groups of RYR (36) . The mean (time constant) for relaxation of the SR-sensitive current was 14 Ϯ 1 ms (single exponential fitting, n ϭ 6). The amplitude of the SR-sensitive current decreased with depolarization (Fig. 4B) .
The dependence of multiphasic decay of I CaL on intracellular Ca 2ϩ and CICR could arise in one of two ways. First, the increase in intracellular Ca 2ϩ could activate a Ca 2ϩ -dependent Cl Ϫ current [I Cl(Ca) ], which would distort the recording of I CaL and provoke an apparently complex decay resulting from the superposition of two different currents. Second, the increase in intracellular Ca 2ϩ could provoke the decay of I CaL via Ca 2ϩ -induced inactivation, which would therefore represent a rapid and transient process that could be reversible on a time scale of tens of milliseconds.
A Ca 2ϩ -activated Cl Ϫ current has been characterized in rabbit, dog, and mouse cardiac cells (41) (42) (43) (44) . In our experimental conditions with the Na ϩ -K ϩ -free extracellular solution and the Cs ϩ -based intracellular solution described in Table 1 , the equilibrium potential for chloride (E Cl ) would be about Ϫ2 mV. In these circumstances a Cl Ϫ current would appear as an inward current at negative membrane potentials and as an outward current at positive membrane potentials. The ryanodine-difference currents shown in Fig. 4 did not reverse direction at or near to 0 mV. They were outwardly directed at all voltages with no signs of reversing; instead, they approached zero asymptomatically with depolarization. If the influx of Ca 2ϩ via I CaL and CICR were to have evoked I Cl(Ca) , this would have appeared during voltage steps to negative membrane potentials as a reduction of the decay of I CaL , which would then be accelerated when ryanodine blocked CICR. In the recordings shown in Fig. 3A , the opposite -rich internal solutions, some myocytes showed an enlarged I CaL amplitude, multiphasic I CaL decay, and prepulse diastolic facilitation, whereas others showed apparently normal control I CaL ? Ca 2ϩ cycling in cardiac cells is known to be very sensitive to phosphorylation, and Barrere-Lemaire et al. (3) showed that the diastolic depolarization-induced facilitation is enhanced by cAMP-dependent phosphorylation. We therefore postulated that the PKA pathway might be active in basal conditions in some cells in the absence of external agonist stimulation. To test this, we superfused cells that showed notched decay of I CaL with a solution that contained 5 M of the PKA inhibitor H-89. Figure  5A shows that this reduced current amplitude, slowed decay (Fig. 5A, inset) , and abolished prepulse voltagedependent facilitation (Fig. 5B, n ϭ 7) . To confirm these results, we used a more specific PKA inhibitor, the PKI peptide. This peptide was included in the pipette solution, and a representative result is presented in Fig. 5C . The amplitude of I CaL gradually decreased with time, and this was associated with the disappearance of the notch (n ϭ 3). Interestingly, the effect on the inactivation phase was more marked with PKI than H-89. This result could be explained by the fact that phosphorylation of PLB may be less sensitive to the effect of H-89 (15) . To check that this decrease of I CaL over time is not due to rundown, we performed the same experiments without PKI in the pipette solution, relationship between the amplitude of the difference current and voltage (n ϭ 6). Difference current amplitude was normalized to that measured at Ϫ20 mV. and no significant decrease of I CaL was observed (Fig.  5C, n ϭ 7) .
We conclude from these experiments that the PKAdependent phosphorylation pathway was active in basal conditions, leading to phosphorylation of the Ltype Ca 2ϩ channel and/or of the RyR and/or PLB. Influence of the intracellular medium on inactivation of I CaL . The next series of experiments was designed to elucidate the mechanism responsible for the apparently high level of phosphorylation in our basal experimental conditions. Vargas et al. (39) showed that Cs ϩ increased PKA activity in vitro. We first compared results from cells in which N-methyl-D-glucamine (NMDG) rather than Cs ϩ replaced intracellular K ϩ (Table 1 ). In basal conditions I CaL never showed notched or multiphasic decay when the myocytes were loaded with NMDG-rich intracellular solution (Fig.  6B) . Table 2 shows that under basal conditions, I CaL in Cs ϩ -loaded cells with notched decay was significantly larger than in those without notched decay, whether they were loaded with Cs ϩ or NMDG (P Ͻ 0.05). The responses of cells with these different intracellular media to ␤-adrenergic stimulation were tested. Figure  6A shows a Ca 2ϩ current elicited at Ϫ10 mV in a cell with Cs ϩ -based pipette solution. This cell clearly showed a notched decay under basal conditions, and the addition of 1 M isoproterenol had only a weak effect on I CaL amplitude. In 11 similar cells, the amplitude of the current was increased significantly by 55 Ϯ 18% by addition of 1 M isoproterenol. Figure 6B shows a Ca 2ϩ current evoked in a cell with an NMDGrich pipette solution. In basal conditions the current did not show notched decay, and the amplitude of the current was strongly increased by addition of 1 M isoproterenol (168 Ϯ 23%, n ϭ 6, P Ͻ 0.05 compared with notched I CaL ). The response of I CaL to isoproterenol in cells with either Cs ϩ -or NMDG-rich intracellular solutions is summarized in Fig. 6C . Cells with multiphasic inactivation of I CaL , although larger under control conditions than in their counterparts with simple decay of I CaL , responded poorly to isoproterenol. Interestingly, cells with monophasic inactivation of I CaL responded to isoproterenol stimulation with an increase in I CaL amplitude of 207 Ϯ 36% (n ϭ 14). As found with NMDG-rich pipette solution, after isoproterenol stimulation I CaL inactivation showed a multiphasic inactivation. To confirm the role of the PKA pathway, we used forskolin to directly stimulate the adenylyl cyclase. We found that the amplitude of I CaL showing multiphasic inactivation increased by only 58 Ϯ 8% (n ϭ 6) with forskolin, whereas in cells presenting I CaL with monophasic decay, I CaL increased by 178 Ϯ 18% (n ϭ 15; data not shown). Forskolin also induced the appearance of the notch during the inactivation phase (n ϭ 14 of 15 cells).
To further investigate the incidence of complex decay of I CaL consecutive to activation of the PKA pathway, we investigated the effects of isoproterenol on I CaL in more physiological conditions with a Na ϩ -rich extracellular solution and a K ϩ -rich intracellular solution (Table 1 ). Figure 7A shows Ca 2ϩ currents elicited by voltage steps to Ϫ40, Ϫ20, and 0 mV in a representative cell. In control conditions the decay of the current was always simple (Fig. 7Aa) . The application of isoproterenol induced a large increase of Ca 2ϩ current amplitude (Fig. 7B) and notched or multiphasic decay (Fig. 7Ab) . As found in the previous experiments with Na ϩ -K ϩ free extracellular and Cs ϩ -rich intracellular solutions (Fig. 3) , multiphasic decay of I CaL in cells with a K ϩ -rich intracellular solution was due to Ca 2ϩ released from the SR, because the addition of ryanodine to the external solution slowed inactivation, removed multiphasic decay (Fig. 7Ac) , and further in- Amplitude of L-type Ca 2ϩ current (ICaL) elicited at 0 mV from a holding potential of Ϫ80 mV with Cs ϩ -or NMDG-based pipette solutions was measured (means Ϯ SE); n ϭ no. of cells studied. With Cs ϩ pipette solutions, ICaL displayed 2 kinds of behavior, either the presence or absence of notched or multiphasic decay. * P Ͻ 0.05 vs. Cs ϩ with notch.
creased current amplitude (Fig. 7B) . In basal conditions ryanodine had no effect on current amplitude (Fig. 7B ).
DISCUSSION
The objective of this study was to elucidate the mechanism that underlies multiphasic inactivation of I CaL recorded in our experimental conditions. The major findings were that in the whole cell configuration of the ruptured patch-clamp technique, Cs ϩ was able to activate the PKA pathway, leading to the phosphorylation of targets such as DHPr and/or RyR and/or PLB that enhanced fast and rapidly reversible inactivation of I CaL by Ca 2ϩ released by the SR. Intracellular Cs ϩ and excitation-contraction studies. Most of the observations here correspond to a particular, but widely used, experimental condition where I CaL is isolated by replacing intracellular K ϩ by Cs ϩ (1, 2, 26). Recently, however, Cs ϩ has been shown to significantly increase the activity of the catalytic subunit of PKA (39) . Though our experiments did not directly measure PKA activity, we recorded the activity of one of the effectors of this pathway, the L-type Ca 2ϩ current. In the majority of cells infused with a Cs ϩ -rich pipette solution under otherwise basal conditions, the application of PKA inhibitors (H-89, PKI) reduced current amplitude and slowed inactivation, causing the disappearance of notched or multiphasic decay. Also, in these cells isoproterenol had only a small effect on the amplitude of I CaL . It was as if the current had already been activated by this signaling pathway, which concords with its greater amplitude under basal conditions. Evidence that these results are due to Cs ϩ and not to the replacement of intracellular K ϩ was shown when cells were infused with NMDG-rich pipette solution, where I CaL was smaller, with normal current decay under basal conditions and greater responsiveness to isoproterenol. Similar results were obtained when quasi-physiological solutions were used in the recording of I CaL . Together, these results strongly suggest that intracellular Cs ϩ activates the PKA pathway. Furthermore, it has been proposed that intracellular Cs ϩ blocks K ϩ channels present on the SR membrane and thereby alters Ca 2ϩ -cycling properties of cardiac cells (17, 22) . Our finding and these findings indicate that care must be taken when Cs ϩ is used instead of K ϩ in the intracellular solution to study excitationcontraction (EC) coupling in cardiac myocytes.
Fast and reversible Ca 2ϩ -dependent inactivation of I CaL . Another result of this study was that in conditions when the PKA pathway was activated, the local release of Ca 2ϩ by the SR (32) was able to rapidly and reversibly inactivate I CaL , which was responsible for the appearance of either multiphasic or notched decay of I CaL . The increase in the initial phase of decay was probably due to an increased Ca 2ϩ concentration underneath the membrane after enhanced SR Ca 2ϩ release. The recovery of I CaL during the maintained voltage step that gave rise to multiphasic decay was probably due to the reduction of Ca 2ϩ concentration in the subsarcolemmal microdomain by diffusion and reuptake by the SR. The channel then came back from the Ca 2ϩ -inactivated state to the open state. The Ca 2ϩ uptake occurs via the SERCA, which must belong to the microdomain. Therefore, DHPr, RyR, and SERCA belong to the same Ca 2ϩ microdomain, not influenced by the presence of the Ca 2ϩ chelator EGTA. Calcium microdomains are known to exist in the rat ventricular cell, but our observations are interesting because the guinea pig myocyte bears more similarity to the human cardiac myocyte (5) . With BAPTA, the notch was never observed, suggesting that the accessibility of EGTA is not sterical but, more likely, limited to the speed necessary to chelate Ca 2ϩ (25) . Further studies are required to determine which of the key proteins was phosphorylated by Cs ϩ activation of PKA: the DHPr, the RyR, or the regulatory protein PLB (6) .
If reversible inactivation were directly linked to the local control of Ca 2ϩ release, this would assume a local release of Ca 2ϩ from the SR that was tightly synchronized to the peak I CaL with a duration of the local SR Ca 2ϩ release event between 7 and 30 ms (5, 36). The fact that notched or multiphasic decay was more prominent at negative membrane potentials agrees with the gain of CICR (40), which increases with the level of phosphorylation (12) . Thus these experiments provide new evidence that fast negative feedback from the release of Ca 2ϩ from the SR to I CaL via Ca 2ϩ -dependent inactivation occurs proportionally to the amplitude of the triggering signal. In this manner, the increase of I CaL upon activation of the PKA phosphorylation pathway would permit the fast and reversible control of EC coupling. This mechanism would play an important role during ␤-adrenergic stimulation of the heart. Finally, it is important to note that those cells that lacked complex inactivation of I CaL under basal conditions acquired it upon the application of isoproterenol. This corroborates the hypothesis that fast inactivation of I CaL mediated by Ca 2ϩ release from the SR requires PKA-dependent phosphorylation.
Low diastolic depolarization facilitation. Diastolic potential-induced facilitation of the I CaL was only observed under basal conditions in this study when Cs ϩ was used to substitute for K ϩ . Barrere-Lemaire et al. (3) , who also used Cs ϩ in their pipette solution, suggested that this phenomenon was linked to CICR Ca 2ϩ -induced inactivation of the L-type Ca 2ϩ current favored by cAMP-dependent phosphorylation. Thus during the prepulse, either a release of Ca 2ϩ from the SR occurred, leading to reduced Ca 2ϩ -dependent inactivation during the subsequent test pulse, or the channel changed to a Ca 2ϩ -insensitive conformation. Whatever the mechanism, it required the PKA phosphorylation of the L-type Ca 2ϩ channel and/or the RyR and/or PLB. It is interesting to note that similar properties have been described for frequency-dependent facilitation, e.g., increase in the amplitude and slowing of the inactivation phase of I CaL (11) .
Some questions remain to be elucidated. Why would only certain cardiomyocytes, under basal conditions, show fast inactivation upregulated by the PKA phosphorylation pathway? Such a question probably finds an answer in the regulatory mechanism proposed by duBell et al. (12) , who suggested that EC coupling, including I CaL , was a dynamic balance between phosphorylation and dephosphorylation. The two kinds of cells described here could therefore correspond to a difference in the equilibrium of such a dynamic process, exacerbated by the presence of Cs ϩ in the internal medium. Populations of cells with monophasic inactivation of I CaL could have a higher basal level of phosphatase activity, as indicated by the lower effect of isoproterenol and forskolin stimulation.
Why have other studies not reported this notched inactivation of I CaL in the same species? Some investigators used NMDG-rich intracellular solution (e.g., see Ref. 35) . In the great majority of the studies in which Cs ϩ was used in the pipette solution, it is likely that investigators missed this point by using a depolarizing prepulse or holding potential (Ϫ40 mV) to inactivate I Na and I CaT (e.g., see Refs. 4, 27, and 31). It is known that a nonphysiological depolarized holding potential interferes with the functioning of the L-type Ca 2ϩ channels, inducing a slowing of the inactivation phase of I CaL (3, 38) . Finally, many investigators have used depolarized test pulses of 0 or ϩ10 mV at which the notch is less pronounced (Fig. 1B) .
In conclusion, we have shown that intracellular Cs ϩ is able to activate the PKA pathway, modifying in consequence the activity of the targets of this kinase. We have shown that PKA activation enhances Ca 2ϩ -dependent inactivation of I CaL , which then closely follows the kinetics of localized variation in [Ca 2ϩ ]. We have shown that diastolic potential-induced facilitation of I CaL is a phenomenon dependent on Ca 2ϩ -dependent inactivation, which also requires activation of the PKA pathway.
